SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001571049-14-004549
Filing Date
2014-09-11
Accepted
2014-09-11 16:38:33
Documents
4
Period of Report
2014-09-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K t1401764_8k.htm 8-K 21042
2 EXHIBIT 99.1 t1401764_ex99-1.htm EX-99.1 13223
3 GRAPHIC logo.jpg GRAPHIC 10036
4 GRAPHIC logo1.jpg GRAPHIC 3618
  Complete submission text file 0001571049-14-004549.txt   54727
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 141098497
SIC: 2834 Pharmaceutical Preparations